Effect of refined coconut oil or copra meal on methane output and on intake and performance of beef heffers

An experiment was conducted to establish the effect of feeding either refined coconut oil (CO) or copra meal containing CO to beef heifers on DMI, animal performance, enteric CH4 emissions, diet digestibility, and the fatty acid profile of the resulting meat. Forty-one Charolais and Limousin crossbred beef heifers (474 +/- 29 kg; 661 +/- 89 d of age) were blocked by BW before being assigned in a randomized complete block design to 1 of 3 experimental treatments (n = 12) or to a pretrial slaughter group (n = 5) used to determine the initial carcass weight. The experimental period lasted for 93 d. Enteric CH4 output was recorded for 2 periods of 5 consecutive days from d 14 to 18 and from d 70 to 74. The 3 dietary treatments were 1) control, a barley/soybean meal-based concentrate with 0 g of CO/ d; 2) RCO, a barley/soybean meal-based concentrate with 250 g of CO/d from refined coconut oil; and 3) CM, a copra meal-based concentrate with 250 g of CO/d from copra meal. Each diet had a 50:50 forage: concentrate using grass silage as the forage source. There was no effect of diet on DMI (P = 0.734) or GE intake (P = 0.486). The addition of RCO increased ADG (P < 0.05) compared with the control treatment. The CM treatment decreased (P < 0.05) average daily carcass gain compared with the RCO treatment only. There was a decrease (P < 0.05) in the digestibility of the DM, OM, CP, and GE fractions of the diet only with the CM treatment. Both the RCO and CM concentrates decreased (P < 0.001) daily enteric CH4 output when expressed in terms of liters per day, liters per kilogram of DMI, percentage of GE intake, liters per kilogram of ADG, and liters per kilogram of average daily carcass gain. The RCO treatment produced the greatest numerical response for all measures. Ruminal protozoa numbers on the RCO treatment were lower (P < 0.05) than on the control treatment. The concentrations of the fatty acid methyl esters, lauric (P < 0.001) and myristic (P < 0.002) acids, were increased in muscle when either of the CCO treatments was compared with the controls, but the differences were of a magnitude unlikely to influence human health status. Although the CM concentrate decreased CH4 comparable with the RCO concentrate, decreased performance resulted in an extended finishing time with implications for lifetime CH4 emissions.